23andMe
23andMe is a consumer genetics and biotechnology company founded in 2006 that sells saliva-based DNA test kits and returns ancestry composition, DNA relative matching, genetic health-predisposition and carrier-status reports, wellness and trait insights, and pharmacogenetic results directly to consumers, alongside a research arm that studies aggregated, consented genetic data. 23andMe historically published a scope-gated, OAuth 2.0 Personal Genome API at api.23andme.com, but closed third-party developer API access in September 2018; the company entered Chapter 11 bankruptcy in 2025 and its consumer web presence and assets have since shifted to the 23andme.org domain. No public, live developer API surface remains, though the company maintains a trust center and a security disclosure program.
23andMe is profiled on the APIs.io network. Tagged areas include Company, Healthtech, Genetics, Genomics, and DNA Testing.
23andMe’s developer surface includes engineering blog, support, and 9 more developer resources.
Kin Score
Security Posture 3
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 5
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API